Rizq, O., Mimura, N., Oshima, M., Saraya, A., Koide, S., Kato, Y., . . . Iwama, A. (2017). Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Clin Cancer Res.
Chicago Style CitationRizq, Ola, et al. "Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition." Clin Cancer Res 2017.
Cita MLARizq, Ola, et al. "Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition." Clin Cancer Res 2017.
Atenció: Aquestes cites poden no estar 100% correctes.